Respiration Scan logo — Respiration Scan diagnoses pneumonia via the human breath vi...

Respiration Scan

Respiration Scan diagnoses pneumonia via the human breath via a novel hardware and AI software approach.

Founded 2017 Israel Israel 9 employees Series A Total: $250.00K Health Care, Manufacturing +1

General Information

Company Name Respiration Scan
Founded Year 2017
Location Israel Israel +2
Employees 9
Industries Health Care, Manufacturing, Medical Devices
Funding Stage Series A
Social

Get notified when Respiration Scan moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Respiration Scan

Respiration Scan is a health care startup based in Israel that has developed a pioneering approach to diagnose pneumonia through analyzing volatile organic compounds (VOCs) in human breath. Founded in 2017, the company has received a $250.00K Series A investment from Newchip Accelerator on 28 December 2022. The company's slogan, "Respiration Scan diagnoses pneumonia via the human breath via a novel hardware and AI software approach," encapsulates their innovative methodology. Respiration Scan's technology stands out in the health care and manufacturing industries, providing clinicians with a revolutionary diagnostic tool. By continuously learning new disease states and expanding their product lines, the RS software has the capacity not only to diagnose but also predict diseases, marking a significant shift in healthcare practices. As the company collects more patient samples, they aim to expand their capability to target more bacterial and viral pathogens in human breath through their AI technology. This signifies a promising future for Respiration Scan as it strives to transform the healthcare paradigm entirely.

Taxonomy: Medical diagnostics, AI in healthcare, Respiratory diseases, Pneumonia diagnosis, Ventilator-associated pneumonia, Healthcare innovation, Volatile organic compounds analysis, Artificial intelligence software, Predictive diagnostics

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 1 •••• •••• 28 Dec 2022

Respiration Scan Alternatives & Competitors

Respiration Scan vs

Diagnostics Reimagined | Rapid Breath Tests for Disease Detection | Covid-19, Lung Cancer and more

Seed
7 employees
Biotechnology, Health Care
Respiration Scan vs
Owlstone Medical
Owlstone Medical United Kingdom

On a mission to save 100k lives and $1.5B healthcare costs

Undisclosed
208 employees
Health Care, Medical Devices
Respiration Scan vs
Noze
Noze Canada

Early disease diagnostics through an AI-powered sense of smell.

Series Unknown
52 employees
AI, Health Care
Also compare with: Respiration Scan vs attained.ai attained.ai Respiration Scan vs RespiQ RespiQ

FAQ About Respiration Scan

Respiration Scan diagnoses pneumonia via the human breath via a novel hardware and AI software approach.
Respiration Scan was founded in 2017.
Respiration Scan is headquartered in Israel.
Respiration Scan operates in the following industries: Health Care, Manufacturing, Medical Devices.
Respiration Scan has approximately 9 employees.
Respiration Scan has completed 1 funding round, raising a total of $250.00K. The latest funding stage is Series A.
Top alternatives and competitors to Respiration Scan include Breathonix Pte Ltd, Owlstone Medical, Noze, attained.ai, ChromX Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Respiration Scan and Breathonix Pte Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Respiration Scan and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy